共 50 条
Medical Prevention of Breast Cancer
被引:11
作者:
Stubert, Johannes
[1
]
Dieterich, Max
[1
]
Gerber, Bernd
[1
]
机构:
[1] Univ Rostock, Dept Obstet & Gynecol, D-18059 Rostock, Germany
来源:
关键词:
Breast cancer;
Prevention;
Tamoxifen;
SERMs;
Aromatase inhibitors;
SURGICAL ADJUVANT BREAST;
NONSTEROIDAL ANTIINFLAMMATORY DRUGS;
BONE-MINERAL DENSITY;
POSTMENOPAUSAL WOMEN;
RANDOMIZED-TRIAL;
BOWEL PROJECT;
CLINICAL-TRIALS;
FAMILY-HISTORY;
FOLLOW-UP;
RISK;
D O I:
10.1159/000369573
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Breast cancer is the most common cancer of women in Western Europe and North America. Effective strategies of medical prevention could reduce the burden of breast cancer mortality. The best evidence for a risk reduction exists for hormonal agents such as tamoxifen and raloxifene (22-72%) or aromatase inhibitors (50-65%). However, the severity of side effects and the lack of evidence for an improved survival compromise the risk/benefit balance. In this review the results of chemoprevention studies, including new treatment approaches, are summarized with critical discussion of their use in clinical practice.
引用
收藏
页码:391 / 396
页数:6
相关论文